United States · FDA National Drug Code directory
Verapamil Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42571-313_5950b3f8-7ff0-509e-e063-6294a90a6720
- Product NDC
- 42571-313
- Form
- INJECTION
- Composition / generic term
- Verapamil Hydrochloride
- Labeler
- Micro Labs Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190304
- Source listing expiry
- 20271231
Source-listed ingredients
- VERAPAMIL HYDROCHLORIDE — 2.5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (42571-313-75) / 2 mL in 1 VIAL · 42571-313-75
- 1 VIAL in 1 CARTON (42571-313-86) / 4 mL in 1 VIAL · 42571-313-86
- 25 VIAL in 1 CARTON (42571-313-87) / 2 mL in 1 VIAL · 42571-313-87
- 5 VIAL in 1 CARTON (42571-313-96) / 4 mL in 1 VIAL · 42571-313-96
- 5 VIAL in 1 CARTON (42571-313-97) / 2 mL in 1 VIAL · 42571-313-97
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →